Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi (MEDTR.IS)
- Previous Close
31.80 - Open
31.68 - Bid 31.48 x --
- Ask 31.56 x --
- Day's Range
31.32 - 31.94 - 52 Week Range
29.72 - 55.00 - Volume
378,855 - Avg. Volume
445,124 - Market Cap (intraday)
3.748B - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
50.81 - EPS (TTM)
0.62 - Earnings Date --
- Forward Dividend & Yield 0.25 (0.79%)
- Ex-Dividend Date Jul 28, 2025
- 1y Target Est
68.90
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers breathing sytems products, including breathing circuits, breathing filters, catheter mounts, gas sampling lines, accessories, masks, and connectors. It also provides hospital products, such as barrier cream, surgical hand brushes for skin disinfection, hand and skin antiseptics, and skin and mucosa antiseptics. In addition, the company engages in the manufacturing and sale of anesthesia and intensive care circuits; installation, operation, and design of oncology drug preparation and delivery systems; production, sales, and technical service of infusion pumps and sets; and manufacturing of biocidal products. It also exports its products to 80 countries under its Altech brand name. Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi was founded in 1983 and is headquartered in Izmir, Turkey.
www.meditera.com.trRecent News: MEDTR.IS
View MorePerformance Overview: MEDTR.IS
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is BIST 100 (XU100.IS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEDTR.IS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEDTR.IS
View MoreValuation Measures
Market Cap
3.78B
Enterprise Value
3.40B
Trailing P/E
51.29
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.81
Price/Book (mrq)
1.70
Enterprise Value/Revenue
1.62
Enterprise Value/EBITDA
14.48
Financial Highlights
Profitability and Income Statement
Profit Margin
3.51%
Return on Assets (ttm)
5.24%
Return on Equity (ttm)
3.22%
Revenue (ttm)
2.09B
Net Income Avi to Common (ttm)
73.43M
Diluted EPS (ttm)
0.62
Balance Sheet and Cash Flow
Total Cash (mrq)
434.09M
Total Debt/Equity (mrq)
2.10%
Levered Free Cash Flow (ttm)
-106.23M